CHANGSHA, China and XIANGTAN, China, May 26, 2017 /PRNewswire/ -- Cancer levels in China are noted to be below many western nations, however there is a growing incidence rate. One of the most prominent forms of cancer on the rise is prostate cancer. Prostate cancer is essentially the growth of cancerous tumors on the male prostate and can leave patients with pain during urination, increase the frequency to urinate, blood in urine, and more. With the male population in China outweighing both women and children, medical researchers have begun to focus on treating and reducing incidence of prostate cancer. The 3D prostate treatment based out of the 3D urology and prostate clinic in China is on the forefront of prostate cancer research and has become recognized around the world for the excellence in helping patients.
Cancer cells are hard to distinguish from non-cancerous cells, they essentially look the same and have similar pathways in formation to non-cancerous cells, the only difference is that there is extensive cell division that is faster than cell death. Extensive cell division causes growths in the forms of tumors to appear and can cause serious damage through exhausting the bodies already finite resources. Cancer treatment often involves using drugs, radiation, and even hormones to target the areas that the tumor has grown. These treatments work by destroying all cells in the area of the tumor, however, this causes adverse side effects when the non-cancerous cells are also destroyed. Research out of the Song lab looks to mediate these issues by researching ways to target the tumor cells directly, reducing toxicity and side reactions to normal cells.
One direct method of targeting cancer cells is through monoclonal antibody therapy. This method of cancer treatment culturing a fusion of myeloma cells and B-cells. These monoclonal antibodies are highly specific and will only bind and disturb certain cells. Medical research at the 3D urology and prostate clinic has begun looking at monoclonal antibody therapy as a possible treatment of prostate cancer.
Monoclonal antibody therapy is still in the novel stage, but like Traditional Chinese medicine looks like a promising solution in targeting specific cells. Metabolic pathways in cancer need to be better understood before this can be used to treat the disease.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-xinping-songs-3d-prostate-treatment--new-research-cancer-cell-specific-treatment-options-300464294.html
SOURCE Dr. Song 3D Urology and 3D Prostate Clinic